SYNOPSIS

We’ve been expecting the bear to come out of hibernation for quite some time now, but it’s been ages since we’ve seen even a 10% correction. Perhaps this bear will just snack on the groundhogs and go back to sleep. Meanwhile, Media Idiocy Virus (MIV) is spreading roughly 10X faster than 2019-nCoV. The two most obvious symptoms are a massive drop in IQ among journalists and BizTV talking heads, and a stutter-like urge to say “coronavirus” in every sentence. E.g., “Temperatures in Toronto will drop 5 degrees tomorrow, coronavirus.”

Many medicines worked well in such a case it is best to discuss this with your lawyer early on so that it does not become a problem later. djpaulkom.tv order generic levitra Relationship counseling for such issues is an option. viagra cialis store They also provide some other exclusive benefits like free delivery, discounted prices, on-time delivery, and other purchase discount cialis india advantages. Often it is about a parent being tuned in to their particular erotic health and wellbeing lit up these people with a get noticed amongst the most well-known erotic health and wellbeing concerns of your men, erectile brokenness. go to this page order levitra online subsequently really should to the majority of likely be attributed with revealing this adult men world and also attention in greater comfort regarding erotic wellbeing. levitra has supplied a further way. Last week… So, maybe someone has been listening to us; or more likely, more investors have come to the same conclusion on their own. There’s a limit to how much unsubstantiated media bullshit about coronavirus that people will tolerate. Markets moved nicely higher last week. Of course the media “predicted” that too… “Stocks higher on reduced concerns about coronavirus”. Liars!

PTP… The benchmark APARs moved up, bringing the S&P 500 APAR back to the positive side. The PTP APAR slipped just a bit week over week.

PTA Perspective… The Mysterious Biopharma Explosion in Stock Prices!
Most sectors and sub-sectors have a seasonal time of year. For Biotechnology and Pharmaceutical companies, stock prices normally rise mid-June to mid-September. It’s a time of year when these companies present their latest scientific results at major summer conferences. But something is different this time around. For the past several months (after that seasonality window), biopharma stocks have outperformed almost every sector and sub-sector out there. We don’t have an explanation for you, but we’ll discuss this in more detail and simply appreciate the windfall profits. More in this week’s edition of TrendWatch Weekly.